Related Experiment Video
Updated: Mar 28, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Expression of Hedgehog Signals and Growth Inhibition by Itraconazole in Endometrial Cancer
Kayo Inoue1, Hiroshi Tsubamoto2, Kazuko Sakata1
1Department of Obstetrics and Gynecology, Hyogo College of Medicine, Mukogawa, Nishinomiya, Hyogo, Japan.
Background:
There exist limited therapeutic opportunities for the treatment of endometrial cancer (EC). Itraconazole, a common anti-fungal agent and a potent inhibitor of the Hedgehog pathway, has been shown to be clinically effective for various types of cancers, but its clinical efficacy for EC is unknown. Herein, we evaluated the efficacy of itraconazole in treating EC.
Materials And Methods:
We performed immunohistochemistry on EC tumour samples including serous endometrial intraepithelial carcinoma (SEIC). We further evaluated the in vitro efficacy of itraconazole for inhibiting proliferation and migration of EC cell lines.
Results:
Sonic Hedgehog and glioma-associated oncogene homolog 1 (GLI1) were expressed in SEIC and endometrioid adenocarcinoma. We found that itraconazole significantly inhibited tumour cell growth in both dose-dependent and time-dependent manners and inhibited migration of HEC-1A cells.
Conclusion:
Hedgehog signaling plays a role in carcinogenesis and malignant progression in EC. Itraconazole at a physiological dose may suppress progression of EC.
Insights
Itraconazole, an anti-fungal drug, effectively inhibits endometrial cancer (EC) cell growth and migration. This study suggests itraconazole may suppress EC progression by targeting the Hedgehog pathway.
Area of Science:
- Oncology
- Pharmacology
Background:
- Limited therapeutic options exist for endometrial cancer (EC).
- Itraconazole, an anti-fungal agent, inhibits the Hedgehog pathway and shows efficacy in various cancers.
- Its efficacy in EC treatment remains unexplored.
Purpose of the Study:
- To evaluate the efficacy of itraconazole in treating endometrial cancer.
- To investigate the role of Hedgehog signaling in EC progression.
Main Methods:
- Immunohistochemistry performed on EC tumor samples, including serous endometrial intraepithelial carcinoma (SEIC).
- In vitro evaluation of itraconazole's effect on EC cell line proliferation and migration.
Main Results:
- Sonic Hedgehog and GLI1 expression confirmed in SEIC and endometrioid adenocarcinoma.
- Itraconazole significantly inhibited EC tumor cell growth in a dose- and time-dependent manner.
- Itraconazole inhibited the migration of HEC-1A cells.
Conclusions:
- Hedgehog signaling is implicated in EC carcinogenesis and malignant progression.
- Physiological doses of itraconazole show potential in suppressing EC progression.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

